Journals in Biotechnology

Advanced Drug Delivery Reviews

ISSN: 0169-409X

The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Algal Research

ISSN: 2211-9264

Biomass, Biofuels and BioproductsAlgal Research is an international phycology journal covering all areas of emerging technologies in algae biology, biomass production, cultivation, harvesting, extraction, bioproducts, biorefinery, engineering, and econometrics. Algae is defined to include cyanobacteria, microalgae, macroalgae, and protists and symbionts of interest in biotechnology. The journal publishes original research and reviews for the following scope: algal biology, including but not exclusive to: phylogeny, biodiversity, molecular traits, metabolic regulation, and genetic engineering, algal cultivation, e.g. phototrophic systems, heterotrophic systems, and mixotrophic systems, algal harvesting and extraction systems, biotechnology to convert algal biomass and components into biofuels and bioproducts, e.g., nutraceuticals, pharmaceuticals, animal feed, plastics, etc. algal products and their economic assessment.Papers in the latter topics should include characterization and analysis in support of such processes and technologies, for example: approaches to biorefinery and biomass characterization, sustainability assessments and analyses, such as techno-economic, life cycle, and resource assessments of systems and processes using algae as a main source of biomass.The journal will not consider manuscripts where the core concept is the experimental design (RSM, CCD or other) in the optimization of a process, or the biological activity of algae extracts without full characterization and identification of the compounds responsible for the bioactivity.Review articles, book reviews and commentaries should only be submitted after consultation with the editors.

Subscriptions

Antiviral Research

ISSN: 0166-3542

Antiviral Research aims to publish manuscripts in the field of prevention and treatment of viral diseases in humans and vertebrate animals, and encourages authors to the submit manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases. The journal is an Official Publication of the International Society for Antiviral Research. The types of papers published in Antiviral Research includes original research reports, short communications, commentaries and invited review* articles on the control of viral infections in humans. The journal’s scope encompasses:antivira... drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.identificatio... and validation of new drug targets;laboratory animal models of viral diseases for antiviral efficacy testing;evolution of drug-resistant viruses and the development of effective counter measures;pathogenesi... of viral diseases and mechanisms of viral evasion of host immune responses;assessment... of drug safety;new or improved vaccines against viral infections of humans; the prevention and treatment of viral diseases of vertebrate animals, and reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis that must be clearly described in the manuscript.Antiviral Research journal does not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We discourage the submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."ISAR members Authors who are ISAR members are encouraged to contact ISAR after their paper has been accepted for publication in order to benefit from their published work being highlighted in ISAR postings on their social media platforms (further details on this will be given in the AVR acceptance letter). *Antiviral Research journal has started a new initiative to publish at least two thematic special issues per year, containing invited reviews in addition to the ad hoc invitations to experts in the areas within the scope of the journal.

Subscriptions

Biocatalysis and Agricultural Biotechnology

ISSN: 1878-8181

Official journal of the International Society of Biocatalysis and Agricultural Biotechnology (ISBAB)Biocatalysis and Agricultural Biotechnology is the official journal of the International Society of Biocatalysis and Agricultural Biotechnology (ISBAB). The journal publishes high quality articles especially in the science and technology of biocatalysis, bioprocesses, agricultural biotechnology, biomedical biotechnology, and, if appropriate, from other related areas of biotechnology. The journal will publish peer-reviewed basic and applied research papers, authoritative reviews, and feature articles.The scope of the journal encompasses the research, industrial, and commercial aspects of biotechnology, including the areas of: biocatalysis; bioprocesses; food and agriculture; genetic engineering; molecular biology; healthcare and pharmaceuticals; biofuels; genomics; nanotechnology; environment and biodiversity; and bioremediation.Types of papers published are: Full-length original research papers; Short communications; Invited reviews; Letters to the Editor.

Subscriptions

Biochemical Engineering Journal

ISSN: 1369-703X

endorsed by Division of Biochemical Engineering, The Society of Chemical Engineers, JapanBiochemical Engineering Journal welcomes submissions from NIH-funded authors. We deposit gold open access articles immediately in PubMed Central. For other articles, we shall deposit the accepted manuscript on behalf of the author to PubMed Central after 12 months (the normal embargo period for this journal is 24 months). For more information, please see here.The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics Biosensors and Biodevices including biofabrication and novel fuel cell development Bioseparations including scale-up and protein refolding/renaturati... Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cellsBioreactor Systems including characterization, optimization and scale-up Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticalsBioma... and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis Protein Engineering including enzyme engineering and directed evolution*Authors are requested to complete a Review Proposal Form for Editorial approval prior to submission of the review article. Proposals can be submitted to biochemical.engineer... or one of the Editors.

Subscriptions

Biochimica et Biophysica Acta: General Subjects

ISSN: 0304-4165

BBA General Subjects invites submissions of original research, hypothesis-driven studies, and reviews that address topics in biochemistry and biophysics. Manuscripts should present significant advancements in our understanding of molecular mechanisms and be of broad scientific interest to a wide audience. Interdisciplinary studies are encouraged. Descriptive studies without biochemical or biophysical mechanistic evidence and insights are discouraged. Preferred topics areBiomedicine: Fundamental and emerging topics in biochemistry/biophys... with potential medical implicationsNanobiol... Nanoparticles, nanotoxicology, nanomedicine; the topics are not limited to formulation of nanoparticles but investigate mechanism of action on cell types or animal models.Omics: Genomics, proteomics, lipidomics, glycomics, bioinformatics experimentally addressing a defined biological question; descriptive bioinformatics studies that rely solely on publicly available data without experimental validation are discouraged.Chemical biology: Chemical compounds, drug mechanisms, synthesis of novel compounds, click chemistryStructural biology: Crystallography, NMR, multimeric proteins, protein dynamics, nucleic acidsNovel complexes: Nucleic acids, pure natural compounds, synthetic compounds, protein complexes, nucleic acid derivativesCellular signaling: Receptor signaling, protein phosphorylation cascades, phosphatases, secondary messengers, transcription regulation, gene expressionGlycobiolo... Sugar metabolites and metabolism, glycosylated proteins, membrane protein, glycosylation, glycomicsMicrobiolog... Fundamental and applied microbiology, emphasizing biochemical and biophysical aspects and mechanistic insights into infection and disease, as well as the mechanism of action of antimicrobials; manuscripts on clinical aspects such as treatment outcomes, clinical trials, and patient management are not suitable for this journal. Redox biology: Redox switches, glutathione and thioredoxin systems, oxygen and nitrogen radical species, superoxide, hydrogen peroxide, hydroxyl radical, nitric oxide, peroxides, hypoxia, redox regulation of transcription factorsNeurobiology: Neuronal growth factors and nerve signaling, glial cells, autonomic and central nervous systemsStem cells: Differentiation, stem cell isolation and cultivation, growth factorsAdvanced molecular imaging technologies: This may include both biochemical and biophysical approaches.Plant biology: Specific emphasis on molecular plant sciences with mechanistic details and their applications through plant biotechnologyMechani... characterization of compounds having biochemical importance and general interest (drug leads, toxicants, nutrients, and metabolites)BBA General Subjects does not consider studies on the biological effects of crude extracts of natural sources, natural extracts, or traditional medicine unless the exact active molecules are identified and singularly characterized and their mechanism of action is experimentally evaluated.

Subscriptions

Biochimica et Biophysica Acta: Proteins and Proteomics

ISSN: 1570-9639

BBA Proteins and Proteomics covers protein structure conformation and dynamics; protein folding; protein-ligand interactions; enzyme mechanisms, models and kinetics; protein physical properties and spectroscopy; and proteomics and bioinformatics analyses of protein structure, protein function, or protein regulation.The journal no longer considers manuscripts dealing with binding of compounds such as drugs or drug analogues to circulatory proteins such as serum albumin. These studies are better accommodated in journals dealing with drug design and development.Manuscri... must advance our insights into the molecular and mechanistic properties of proteins. Computational studies must generally be validated or complemented by experimental studies. Studies only consisting of computational work will not be considered unless they provide new theoretical insight that allows us to better understand or reinterpret surprising or unexpected experimental data.Comparative proteomics studies are generally not considered for review unless they provide specific insights into the structural and/or functional properties of individual proteins. Proteomics studies must also address properties of individual proteins and should as far as possible be validated by direct investigations of relevant identified proteins.Concise and comprehensive reviews of recent developments are considered for publication. However, authors are strongly advised to consult one of the Executive Editors before starting a review.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Biocybernetics and Biomedical Engineering

ISSN: 0208-5216

Biocybernetics and Biomedical Engineering is a quarterly journal, founded in 1981, devoted to publishing the results of original, innovative and creative research investigations in the field of Biocybernetics and biomedical engineering, which bridges mathematical, physical, chemical and engineering methods and technology to analyse physiological processes in living organisms as well as to develop methods, devices and systems used in biology and medicine, mainly in medical diagnosis, monitoring systems and therapy. The Journal's mission is to advance scientific discovery into new or improved standards of care, and promotion a wide-ranging exchange between science and its application to humans. Biocybernetics and Biomedical Engineering encourages contributions on all aspects of research and developments in: biosystems, including biomedical modeling; cell and tissue engineering for repair medicine; biomeasurements, including biosignal processing and biosensing systems; artificial and hybrid (bioartificial) organs; biomaterials; biomechanics and rehabilitation, including orthopedics and sports medicine; medical information systems and neuronal networks; information and communication technologies in medicine, including brain-computer interfaces; medical imaging, including brain functional magnetic resonance imaging (fMRI); bioinformatics, including genome analysis; and medical physics.The journal welcomes original research articles, reviews and short communications.Biocy... and Biomedical Engineering (BBE) is the official journal of the Nalecz Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences.Please see our Guide for Authors for information on article submission.

Subscriptions

Biologicals

ISSN: 1045-1056

Official Journal of the International Alliance for Biological StandardizationBiolo... provides a modern and multidisciplinary international forum for the publication of research that advances the development, manufacturing, quality control, standardization, safety, efficacy, and regulatory aspects of human and veterinary biological products derived from both novel and established biotechnologies. Special issues are produced to reflect topics of particular international interest and concern. Three types of papers are welcome: original research reports, short papers, and review articles. The journal will also publish comments and letters to the editor, book reviews, meeting reports and information on regulatory issues.Research Areas includeAreas relevant to biologicals for human and veterinary use such as:• Bacterial vaccines • Blood products • Cell biology • Cell culture technology • Cellular immunology • Cytokines and allied mediators • Diagnostics • Downstream processing • Gene transfer and expression • General bacteriology • General virology, endogenous and adventitious viruses • Hormones • Immunochemistry • Molecular biology • Monoclonal antibodies • Parasitology • Prion and prion disease • Protein chemistry • Toxins • Toxoids • Viral vaccines

Subscriptions

Biomaterials

ISSN: 0142-9612

Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.Click here for New Editorial Instructions.Benefit... to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterBiomaterials is the flagship title in Elsevier's biomaterials science portfolio; it sits alongside Materials Today Bio, Biomaterials Advances and Biomaterials and Biosystems . As part of the broader Materials Today family, Biomaterials offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!

Subscriptions

Related subjects

Bio and phyto remediation

Bioengineering and manufacturing

Biomedical engineering

Biomolecular engineering

Biopharmaceuticals

Biosensors

Biotechnology general

Biotechnology in health care

Diagnostics and immunology

Environmental biotechnology

Genomics and proteomics

Industrial microbiology enzymology

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Biotechnology

Advanced Drug Delivery Reviews

Algal Research

Antiviral Research

Biocatalysis and Agricultural Biotechnology

Biochemical Engineering Journal

Biochimica et Biophysica Acta: General Subjects

Biochimica et Biophysica Acta: Proteins and Proteomics

Biocybernetics and Biomedical Engineering

Biologicals

Biomaterials

Related subjects